一种基于细胞结合相关基因的新型分子分类,用于预测急性髓性白血病的临床结果和治疗反应

相关实验视频

Updated: Jun 14, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Fangmin Zhong¹, Fangyi Yao¹, Qin Bai¹

¹Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

|September 2, 2024

概括

清除死细胞的过程 - - 细胞分裂 (Efferocytosis) - - 极大地影响了急性髓性白血病 (AML) 的免疫微环境. 识别埃弗洛细胞化亚型可以指导个性化的AML治疗策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

巨介导的血细胞增生与急性髓性白血病 (AML) 的免疫抑制有关.
埃弗洛细胞在AML中的精确调节作用需要进一步调查.

研究的目的:

在AML中识别与细胞结合相关的分子亚型.
开发一种细胞结核评分模型,用于AML的预后预测和治疗指导.

主要方法:

识别关键的与乙细胞形成相关的基因 (ERG).
达成共识的聚类来定义分子亚型.
构建和验证一个细胞结核分数模型.

主要成果:

确定了三种不同的亚型 (免疫激活,沙漠,免疫抑制).
细胞结核分数模型准确量化亚型并预测预后.
较高的细胞结核分数与预后不佳和抗PD-1治疗的潜在益处相关;较低的分数表明更好的预后和化疗敏感性.

结论:

乙细胞增生显著影响AML免疫微环境.
个别的乙细胞体亚型可以为AML提供个性化治疗策略.

关键词:

急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.有效的细胞分裂.免疫的景观.免疫治疗是一种免疫疗法.分子子类型分子子类型预测预后预测预测

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...